Successful use of tacrolimus for treatment‐refractory neuroblastoma‐associated opsoclonus‐myoclonus‐ataxia syndrome: A case series
S Delap, N Shah, O Kuns, B Franklin… - Pediatric Blood & …, 2024 - Wiley Online Library
Opsoclonus‐myoclonus‐ataxia syndrome (OMAS) is an autoimmune central nervous system
disorder, primarily manifesting as a paraneoplastic sequalae to neuroblastoma, and …
disorder, primarily manifesting as a paraneoplastic sequalae to neuroblastoma, and …
[HTML][HTML] Safety of Obinutuzumab in Children With Autoimmune Encephalitis and Early B-Cell Repopulation on Rituximab
AT Nguyen, C Cotteret, C Gins, E Sarda, C Durrleman… - Pediatric Neurology, 2024 - Elsevier
Background Rituximab (RTX) resistance or early B-cells repopulation were observed in
children but only few publications reported the use of Obinutuzumab and no …
children but only few publications reported the use of Obinutuzumab and no …